115 related articles for article (PubMed ID: 35176860)
21. Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity.
Erdag B; Balcioglu KB; Kumbasar A; Celikbicak O; Zeder-Lutz G; Altschuh D; Salih B; Baysal K
Mol Biotechnol; 2007 Jan; 35(1):51-63. PubMed ID: 17401149
[TBL] [Abstract][Full Text] [Related]
22. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
23. Discovery and Characterization of a High-Affinity Small Peptide Ligand, H1, Targeting FGFR2IIIc for Skin Wound Healing.
Zhao Y; Wang Q; Jin Y; Li Y; Nie C; Huang P; Li Z; Zhang B; Su Z; Hong A; Chen X
Cell Physiol Biochem; 2018; 49(3):1033-1048. PubMed ID: 30196288
[TBL] [Abstract][Full Text] [Related]
24. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
Lamdan H; Gavilondo JV; Muñoz Y; Pupo A; Huerta V; Musacchio A; Pérez L; Ayala M; Rojas G; Balint RF; Larrick JW
Mol Biosyst; 2013 Aug; 9(8):2097-106. PubMed ID: 23702826
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
26. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
[TBL] [Abstract][Full Text] [Related]
27. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
29. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
30. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
[TBL] [Abstract][Full Text] [Related]
31. Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library.
Lee YC; Huang HT; Chang CD; Chen CT; Lin TY; Yang TW; Chang FL; Lu MK; Chiou CT; Chen WC; Pan SL; Tsai KC
Int Immunopharmacol; 2020 Nov; 88():107007. PubMed ID: 33182041
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary study on the effect of vascular endothelial growth factor-loaded self-assembled peptide hydrogel on angiogenesis and vascularization of human umbilical vein endothelial cells].
Zhang RJ; Wang XZ; Liu Y; Zheng SG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Oct; 55(10):757-764. PubMed ID: 33045788
[No Abstract] [Full Text] [Related]
34. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model.
Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM
Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199
[TBL] [Abstract][Full Text] [Related]
35. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.
Liang WC; Wu X; Peale FV; Lee CV; Meng YG; Gutierrez J; Fu L; Malik AK; Gerber HP; Ferrara N; Fuh G
J Biol Chem; 2006 Jan; 281(2):951-61. PubMed ID: 16278208
[TBL] [Abstract][Full Text] [Related]
36. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators.
Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R
ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184
[TBL] [Abstract][Full Text] [Related]
37. Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.
Li W; Ran Y; Li M; Zhang K; Qin X; Xue X; Zhang C; Hao Q; Zhang W; Zhang Y
BMC Biotechnol; 2013 Sep; 13():77. PubMed ID: 24073737
[TBL] [Abstract][Full Text] [Related]
38. Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library.
Shi LF; Wu Y; Li CY
J Gynecol Oncol; 2015 Oct; 26(4):327-35. PubMed ID: 26197772
[TBL] [Abstract][Full Text] [Related]
39. Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
Vicari D; Foy KC; Liotta EM; Kaumaya PT
J Biol Chem; 2011 Apr; 286(15):13612-25. PubMed ID: 21321115
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
